Nature’s Fynd Begins Production, Raises $80 Million Series B to Commercialize a New-to-the-World Protein
Sigilon Therapeutics Announces $80.3 Million Series B Financing to Advance Shielded Living Therapeutics™ to the Clinic
ZBiotics, World’s First Maker of Genetically Engineered Probiotics, Raises $2.3M to Bring Additional GMO Probiotics to the World
Octarine Bio IVS Receives Funding from Vækstfonden to Develop Biosynthetic Platform for Cannabinoid and Psychedelic Tryptamine Derivatives
